YLYing-Chih Lin

Ying-Chih Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying-Chih Lin has a total of 296 co-authors. Here are the top co-authors by number of shared publications:

  • Yu Wang

    Department of Chemistry, National Taiwan University, Taipei, Taiwan 106, Republic of China

    49 shared publications
  • Shou-Ling Huang

    Department of Chemistry, National Taiwan University, No 1 Sec 4 Roosevelt Road, Taipei, Taiwan 10617

    21 shared publications
  • Gene-Hsiang Lee

    National University Preparatory School for Overseas Chinese Students, Linkou, Taipei Hsien 244, Taiwan, Republic of China, and Department of Chemistry, National Taiwan University, Taipei 106, Taiwan, Republic of China

    17 shared publications
  • Yi-Hong Liu

    Department of Chemistry, National Taiwan University, Taipei, Taiwan 106, Republic of China

    14 shared publications
  • Shou‐Ling Huang

    Department of Chemistry National (Taiwan) University Taipei 106 Taiwan

    12 shared publications
  • Yi‐Hung Liu

    Department of Chemistry, National Taiwan University, Taipei, 106, Taiwan), Fax: (+886) 223636359

    10 shared publications

Latest Publications

  • Open Access

    Data from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair

    by Eva M. Goellner, Bradford Grimme, Ashley R. Brown, Ying-Chih Lin, Xiao-Hong Wang, Kelsey F. Sugrue, Leah Mitchell, Ram N. Trivedi, Jiang-Bo Tang, Robert W. Sobol

  • Open Access

    Supplementary Methods, Figures 1-6, Table 1 from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair

    by Eva M. Goellner, Bradford Grimme, Ashley R. Brown, Ying-Chih Lin, Xiao-Hong Wang, Kelsey F. Sugrue, Leah Mitchell, Ram N. Trivedi, Jiang-Bo Tang, Robert W. Sobol

    Supplementary Methods, Figures 1-6, Table 1 from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair

  • Intermolecular Dehydrative Coupling and Intramolecular Cyclization of Ruthenium Vinylidene Complexes Formed from Aromatic Propynes Containing Carbonyl Functionalities

    by Pi‐Yeh Chia, Cheng‐Chen Kuo, Shou‐Ling Huang, Yi‐Hong Liu, Ling‐Kang Liu, Ying‐Chih Lin

    A remarkable intermolecular dehydrative coupling reaction with the formation of a C−C bond was found for the vinylidene complex 2 a, yielding the dinuclear bisvinylidene complex 4 a. Complex 2 a containing 1‐hydroxyindan moiety was first formed from the reaction of o‐propynyl benzaldehyde 1 a with [Ru]–Cl ([Ru]=Cp(PPh3)2Ru) by a cyclization process. For analogous aldehyde 1 b containing an additional 1,3‐dioxolane group on the aryl ring, similar intermolecular coupling yields the dinuclear bisvinylidene complex 4 b. However, the fluoro group on the aryl ring in aldehyde 1 c inhibits the coupling reaction, giving only the vinylidene complex 2 c. For the reactions of [Ru]–Cl in MeOH with compounds 1 f, 1 g and 1 h, each with a ketone functionality, cyclization gives vinylidene complexes 2 f, 2 g and 2 h, respectively. However, no similar intermolecular coupling was observed, instead, the intramolecular dehydration yields 8 f, 8 g and 8 h, respectively. In CDCl3, catalytic cyclization is observed for the o‐propynylphenyl ketone 1 h with [Ru]–Cl at 50 °C giving the isochromene products 14 h. Furthermore, treatment of the o‐propynylaryl α,β‐unsaturated ketones 1 k–m and 1 n with [Ru]–Cl in MeOH affords the corresponding vinylidene complexes 10 k–m and 11 n each with 1‐benzosuberone moiety in the presence of NH4PF6. These intramolecular cyclization products were formed by the addition of Cβ onto the terminal carbon of the alkene moiety. All these reaction products were characterized by spectroscopic methods. In addition, structures of complexes 4 a, and 10 l were confirmed by single crystal X‐ray diffraction analysis.


  • Cyclization Reactions of Aryl Propargyl Acetates with Tethered Epoxide Induced by Ruthenium Complex

    by Yi‐Jhen Feng, Yi‐Hsin Chen, Shou‐Ling Huang, Yi‐Hung Liu, Ying‐Chih Lin

    Reactions of the ruthenium complex [Ru]Cl ([Ru]=Cp(PPh3)2Ru; Cp=η5‐C5H5) with several aryl propargyl acetates, each with an ortho‐substituted chain of various length containing an epoxide on the aromatic ring and with or without methyl substitutents on the epoxide ring, bring about novel cyclizations. The cyclization reactions of HC≡CCH(OAc)(C6H4)CH2(RC2H2O) (R=H, 6 a; R=CH3, 6 b, where RC2H2O is an epoxide ring) in MeOH give the vinylidene complexes 5 a–b, respectively, each with the Cβ integrated into a tetrahydro‐5H‐benzo[7]annulen‐6‐ol ring. A C−C bond formation takes place between the propargyl acetate and the less substituted carbon of the epoxide ring. Further cyclizations of 5 a–b induced by HBF4 give the corresponding vinylidene complexes 8 a–b each with a new 8‐oxabicyclo‐[3.2.1]octane ring by removal of a methanol molecule in high yield. For similar aryl propargyl acetates with a shorter epoxide chain, the cyclization gives a mixture of a vinylidene complex with a tetrahydronaphthalen‐1‐ol ring and a carbene complex with a tricyclic indeno‐furan ring. For the cyclization of 18, with a longer epoxide chain, opening of the epoxide is required to afford the vicinal bromohydrin 22, then tandem cyclization occurs in one pot. Products are characterized by spectroscopic methods as well as by XRD analysis.


  • Reactions of Ruthenium Complexes Containing Pentatetraenylidene Ligand

    by Shih‐Hung Tsai, Ying‐Chih Lin, Yi‐Hung Liu

    Two ruthenium acetylide complexes [Ru]−C≡C−C≡C−C(OR)(C3H5)2 (2, R=H and 2 a, R=CH3; [Ru]=Cp(PPh3)2Ru) each with two cyclopropyl rings were synthesized from TMS−C≡C−C≡C−C(OH)(C3H5)2 (1; TMS=trimethylsilyl). Treatments of 2 and 2 a with allyl halide in the presence of KPF6 afforded the vinylidene complexes 3 and 3 a, respectively. When NH4PF6 was used, instead of KPF6, additional ring‐opening reaction took place on one of the three‐membered ring. Treatment of [Ru]Cl with 1,3‐butadiyne (6), bearing an epoxide ring, afforded acetylide complex 7 with a furyl ring. Treatment of 2 a with Ph3CPF6 presumably afforded pentatetraenylidene complex {[Ru]=C=C=C=C=C(C3H5)2}[PF6] (10), which was not isolated. Additions of various alcohols in a solution of 10 generated a number of disubstituted allenylidene complexes {[Ru]=C=C=C(OR)−C=C(C3H5)2}[PF6] (11). Treatment of 11 with K2CO3 afforded the acetylide complex 12 bearing a carbonyl group, characterized by single X‐ray diffraction analysis. Addition of a primary amine to 10 caused cleavage of the farthermost C=C bond and several allenylidene complexes {[Ru]=C=C=C(Me)(NHR)}[PF6] (18) were isolated.


  • Ring Expansion and Skeletal Rearrangement of Propargyl Alcohol Substituted Aziridines Induced by Ruthenium Complexes

    by Shu‐Hao Wan, Ying‐Chih Lin, Ling‐Kang Liu, Yi‐Hung Liu

    The ring expansion and skeletal rearrangement of two types of propargyl alcohol substituted aziridines with or without cycloalkane moieties was induced by a ruthenium cyclopentadienyl phosphine complex. In the simple aziridine system with no cycloalkane, the unique cycloisomerization process altered the absolute connectivity of the two‐carbon unit in the three‐membered ring to give organometallic products with substituted pyridine or dihydropyridine ligands. For the aziridine on a cyclohexyl ring, the cycloisomerization process was controlled by an interchange process between vinylidene and allenylidene species, thus creating a better relative configuration of the aziridinyl and the alkynyl units. This determines the stereochemistry of the metal carbene products of the octahydroindole derivatives. The structures of five products were determined by X‐ray diffraction analysis.


  • Cyclization of 2‐Ethynylphenyl Vinyl Ether Catalyzed by a Ruthenium Complex: Mechanism of Catalytic Cyclization and Stoichiometric Cycloisomerization

    by Chi‐Ren Chen, Ying‐Xuan Lai, Rong‐Yu Wu, Yi‐Hung Liu, Ying‐Chih Lin

    Catalytic cyclization reactions and new stoichiometric skeletal rearrangement cycloisomerizations of 2‐ethynylphenyl vinyl ethers containing methyl substituents on the vinyl groups by using [Ru]Cl {[Ru]=Cp(PPh3)2Ru, Cp=η5‐cyclopentadienyl} were observed in MeOH and CH2Cl2, respectively. In MeOH, the catalytic cyclization of three different enynes gave the corresponding benzoxepine derivatives in high yields in each case. Interestingly, in the stoichiometric reactions of [Ru]Cl with enynes, two unprecedented rearrangements of enynes were observed in CH2Cl2. The presence of a methyl group in the vinyl unit plays a critical role in choosing one of the double bonds of the vinylidene ligand, that is, the Ru=Cα or the Cα=Cβ bond, for the [2+2] cycloaddition in the cycloisomerization processes. Structure determination by single‐crystal X‐ray diffraction analysis along with various isotope studies corroborated the proposed mechanisms.


  • Heteroleptic Ruthenium Sensitizers with Hydrophobic Fused‐Thio­phenes for Use in Efficient Dye‐­Sensitized Solar Cells

    by Zong‐Zhan Lu, Jia‐De Peng, An‐Kai Wu, Chun‐Han Lin, Chun‐Guey Wu, Kuo‐Chuan Ho, Ying‐Chih Lin, Kuang‐Lieh Lu

    Two fused‐thiophene‐containing ruthenium sensitizers, [Ru(Hdcbpy)(ottip)(NCS)2]–·0.5[H]+·0.5[N(C4H9)4]+ [Z1, H2dcbpy = 4,4′‐dicarboxy‐2,2′‐bipyridine, ottip = 2‐(5‐octylthieno[3,2‐b]thiophen‐2‐yl)‐1H‐imidazo[4,5‐f][1,10]phenanthroline] and [Ru(Hdcbpy)(odttip)(NCS)2]–·0.5[H]+·0.5[N(C4H9)4]+ {Z2, odttip = 2‐[6‐octyldithieno(3,2‐b:2′,3′)thiophen‐2‐yl]‐1H‐imidazo[4,5‐f][1,10]phenanthroline}, were designed for use in dye‐sensitized solar cell (DSSC) applications. The fused‐thiophene‐based Z1 and Z2 have stronger light‐harvesting capabilities compared with a non‐fused‐thiophene analog, [Ru(Hdcbpy)(otip)(NCS)2]–·0.5[H]+·0.5[N(C4H9)4]+ [JF‐2t, otip = 2‐(5‐octylthiophen‐2‐yl)‐1H‐imidazo[4,5‐f][1,10]phenanthroline], and a standard N3 dye. The power‐conversion efficiency of the Z1‐ and Z2‐sensitized solar cells were superior (8.70 % and 8.15 %) to JF‐2t‐ and N3‐sensitized solar cells (7.85 and 7.40 %, respectively) under standard AM1.5G full sunlight irradiation. The photovoltaic performance of Z1 was better than Z2, primarily owing to the fact that Z1‐based cells have a higher level of dye loading and less charge recombination, as seen from the electrochemical impedance spectroscopy data. This study not only demonstrates the excellent power‐conversion efficiency of new fused‐thiophene ruthenium sensitizers, but also points to the promise that fused‐thiophene antennas might be a useful molecule in the engineering of ruthenium dyes for DSSCs.


  • Reactions of a Ruthenium Complex with Substituted N‐Propargyl Pyrroles

    by Pi‐Yeh Chia, Shou‐Ling Huang, Yi‐Hong Liu, Ying‐Chih Lin

    In an investigation into the chemical reactions of N‐propargyl pyrroles 1 a–c, containing aldehyde, keto, and ester groups on the pyrrole ring, with [Ru]−Cl ([Ru]=Cp(PPh3)2Ru; Cp=C5H5), an aldehyde group in the pyrrole ring is found to play a crucial role in stimulating the cyclization reaction. The reaction of 1 a, containing an aldehyde group, with [Ru]−Cl in the presence of NH4PF6 yields the vinylidene complex 2 a, which further reacts with allyl amine to give the carbene complex 6 a with a pyrrolizine group. However, if 1 a is first reacted with allyl amine to yield the iminenyne 8 a, then the reaction of 8 a with [Ru]−Cl in the presence of NH4PF6 yields the ruthenium complex 9 a, containing a cationic pyrrolopyrazinium group, which has been fully characterized by XRD analysis. These results can be adequately explained by coordination of the triple bond of the propargyl group to the ruthenium metal center first, followed by two processes, that is, formation of a vinylidene intermediate or direct nucleophilic attack. Additionally, the deprotonation of 2 a by R4NOH yields the neutral acetylide complex 3 a. In the presence of NH4PF6, the attempted alkylation of 3 a resulted in the formation the Fischer‐type amino–carbene complex 5 a as a result of the presence of NH3, which served as a nucleophile. With KPF6, the alkylation of 3 a with ethyl and benzyl bromoacetates afforded the disubstituted vinylidene complexes 10 a and 11 a, containing ester groups, which underwent deprotonation reactions to give the furyl complexes 12 a and 13 a, respectively. For 13 a, containing an O‐benzyl group, subsequent 1,3‐migration of the benzyl group was observed to yield product 14 a with a lactone unit. Similar reactivity was not observed for the corresponding N‐propargyl pyrroles 1 b and 1 c, which contained keto and ester groups, respectively, on the pyrrole ring.


  • Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme

    by Jingwen Yao, Chao-Hsiung Hsu, Zhao Li, Tanya S. Kim, Lian-Pin Hwang, Ying-Chih Lin, Yung-Ya Lin

    Glioblastoma multiforme (GBM) is one of the most challenging diseases to treat in clinical oncology due to its high mortality rates and inefficient conventional treatment methods. Difficulties with early detection, post-surgical recurrences, and resistance to chemotherapy and/or radiotherapy are important reasons for the poor prognosis of those with GBM. Over the past few decades, magnetic resonance (MR) theranostics using magnetic nanoparticles has shown unique advantages and great promises for the diagnosis and treatment of cancers. Magnetic nanoparticles not only serve as "molecular beacons" to enhance tumor contrast in magnetic resonance imaging (MRI), but also serve as "molecular bullets" for targeted drug delivery, controlled release, and induced hyperthermia. Moreover, multiple functions of magnetic nanoparticles can be synergistically engineered into a single nanoplatform, making it possible to simultaneously image, treat, target, and monitor the targeted lesions. The multi-functionality of nanoparticles, also called nano-theranostics, gives rises to effective new approaches for combating GBM. In this work, recent research and progress concerning the applications of MR nano-theranostics on GBM using magnetic nanoparticles will be highlighted, focusing on topics such as diagnosis, therapy, targeting, and hyperthermia, as well as outstanding challenges for MR nanotheranostics in treating GBM. The conclusions are generally applicable to other types of brain tumors.